{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T16:39:33Z","timestamp":1782837573259,"version":"3.54.5"},"reference-count":45,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapeutics and Clinical Risk Management"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.2147\/tcrm.2007.3.2.259","type":"journal-article","created":{"date-parts":[[2007,5,27]],"date-time":"2007-05-27T21:05:01Z","timestamp":1180299901000},"page":"259-268","source":"Crossref","is-referenced-by-count":91,"title":["Natalizumab: A new treatment for relapsing remitting multiple sclerosis"],"prefix":"10.2147","volume":"3","author":[{"given":"Michael","family":"Hutchinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","reference":[{"key":"p_1_559","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.21.11472"},{"key":"p_2_560","doi-asserted-by":"publisher","DOI":"10.1191\/1352458503ms896oa"},{"key":"p_3_561","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1242\/jcs.111.9.1165","volume":"111","author":"Bayless KJ","year":"1998","journal-title":"J Cell Sci"},{"key":"p_4_562","doi-asserted-by":"crossref","first-page":"P130","DOI":"10.1191\/1352458502ms776oa","volume":"8","author":"Bennett D","year":"2002","journal-title":"Mult Scler"},{"key":"p_5_563","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830211132"},{"key":"p_6_564","unstructured":"Calabresi P, Giovannoni G, Confavreux C, etal 2007. Incidence and clinical significance of antibodies during treatment with natalizumab: 2 year results from AFFIRM and SENTINEL. Neurology, in press."},{"key":"p_7_565","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1182\/blood.V76.5.965.965","volume":"76","author":"Carlos TM","year":"1990","journal-title":"Blood"},{"key":"p_8_566","unstructured":"Clark W, Mucklow J. 1998. Gathering and weighing the evidence. In Panton R, Chapman S, eds. Medicines management. London: BMJ Books and Pharmaceutical, Pr., pp 59-74."},{"key":"p_9_567","doi-asserted-by":"crossref","unstructured":"Cohen BA, Mikol DD. 2004. Mitoxantrone treatment of multiple sclerosis: safety considerations. Neurology, 63(12 suppl 6):S28-32.","DOI":"10.1212\/WNL.63.12_suppl_6.S28"},{"key":"p_10_568","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-004-0332-4"},{"key":"p_11_569","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.15.6403"},{"key":"p_12_570","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(90)90661-W"},{"key":"p_13_571","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12512-3"},{"key":"p_14_572","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.162.19.2161"},{"key":"p_15_573","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.59.6.909"},{"key":"p_16_574","unstructured":"Goodman AD, Rossman HS, Bar-Or A, etal 2005. GLANCE: a doubleblind, randomized, placebo-controlled, parallel-group safety study of natalizumab in combination with glatiramer acetate in subjects with relapsing-remitting multiple sclerosis. Program and abstracts of the American Academy of Neurology 57th Annual Meeting; April 9-16, 2005; Miami Beach, Florida. Abstract S36.003."},{"key":"p_17_575","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1212\/WNL.43.4.655","volume":"43","author":"IFNB Multiple Sclerosis Study Group","year":"1993","journal-title":"Neurology"},{"key":"p_18_576","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410390304"},{"key":"p_19_577","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1212\/WNL.45.7.1268","volume":"45","author":"Johnson KP","year":"1995","journal-title":"Neurology"},{"key":"p_20_578","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051782"},{"key":"p_21_579","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp058129"},{"key":"p_22_580","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3233\/HAB-1997-8102","volume":"8","author":"Leger OJP","year":"1997","journal-title":"Hum Antibodies"},{"key":"p_23_581","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1172\/JCI117519","volume":"94","author":"Lobb RR","year":"1994","journal-title":"J Clin Invest"},{"key":"p_24_582","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020696"},{"key":"p_25_583","unstructured":"[MSIF] Multiple Sclerosis International Federation. 2006. Introduction [online]. Accessed 9 August 2006. URL: http:\/\/www.msif.org\/en\/ ms_the_disease\/."},{"key":"p_26_584","doi-asserted-by":"crossref","unstructured":"Munari L, Lovati R, Boiko A. 2003. Therapy with glatiramer acetate for multiple sclerosis. Cochrane Database of Syst Rev, 4:CD004678.","DOI":"10.1002\/14651858.CD004678"},{"key":"p_27_585","unstructured":"[NMSS] National Multiple Sclerosis Society. 2006. Research fact sheet [online]. Accessed 9 August 2006. URL: http:\/\/www.nationalmssociety. org\/pdf\/research\/ResearchFactSheet.pdf."},{"key":"p_28_586","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20859"},{"key":"p_29_587","unstructured":"O'Connor PW, Goodman A, Kappos L, etal 2006. The safety and tolerability of natalizumab: results from the safety-extension study in patients with multiple sclerosis. Poster presented at: 58th Annual Meeting of the American Academy of Neurology; April 1-8, 2006; San Diego, California."},{"key":"p_30_588","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1212\/01.WNL.0000128136.79044.D6","volume":"62","author":"O'Connor PW","year":"2004","journal-title":"Neurology"},{"key":"p_31_589","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(89)90775-7"},{"key":"p_32_590","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa044397"},{"key":"p_33_591","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)03334-0"},{"key":"p_34_592","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1212\/WNL.56.12.1628","volume":"56","author":"Prevention of Relapses and Disability by Interferon-beta-1a Subcutaneously in Multiple Sclerosis Study Group","year":"2001","journal-title":"Neurology"},{"key":"p_35_593","doi-asserted-by":"crossref","unstructured":"Rice G PA, Incorvaia B, Munari L, etal 2001. Interferon in relapsingremitting multiple sclerosis. Cochrane Database Syst Rev, 4: CD002002.","DOI":"10.1002\/14651858.CD002002"},{"key":"p_36_594","first-page":"A381","volume":"66","author":"Rudick RA","year":"2006","journal-title":"Neurology"},{"key":"p_37_595","doi-asserted-by":"publisher","DOI":"10.1586\/14737175.4.4.571"},{"key":"p_38_596","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa044396"},{"key":"p_39_597","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1212\/WNL.52.5.1072","volume":"52","author":"Sheremata WA","year":"1999","journal-title":"Neurology"},{"key":"p_40_598","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1212\/WNL.53.3.466","volume":"53","author":"Tubridy N","year":"1999","journal-title":"Neurology"},{"key":"p_41_599","unstructured":"[Tysabri PI] Biogen Idec, Inc. 2006. TysabriR(natalizumab) package insert. Cambridge, MA: Biogen Idec, Inc."},{"key":"p_42_600","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051586"},{"key":"p_43_601","doi-asserted-by":"publisher","DOI":"10.1191\/1352458504ms1084oa"},{"key":"p_44_602","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199206000-00002"},{"key":"p_45_603","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa054693"}],"container-title":["Therapeutics and Clinical Risk Management"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T07:59:08Z","timestamp":1628927948000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/natalizumab-a-new-treatment-for-relapsing-remitting-multiple-sclerosis-peer-reviewed-article-TCRM"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["10.2147\/tcrm.2007.3.2.259"],"URL":"https:\/\/doi.org\/10.2147\/tcrm.2007.3.2.259","relation":{},"ISSN":["1176-6336"],"issn-type":[{"value":"1176-6336","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}